Technical Analysis for MIR - Medmira Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 0.095 | 18.75% | 0.015 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Crossed Above 50 DMA | Bullish | 0.00% | |
| MACD Bullish Centerline Cross | Bullish | 0.00% | |
| Expansion Breakout | Bullish Swing Setup | 0.00% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Reversal New Highs Setup | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% |
| Alert | Time |
|---|---|
| 2x Volume Pace | 3 days ago |
| 1.5x Volume Pace | 3 days ago |
| 50 DMA Resistance | 3 days ago |
| 10 DMA Resistance | 3 days ago |
| Gapped Up (Full) | 4 days ago |
Get a Trading Sidekick!
- Earnings date: 2024-06-27
Medmira Inc Description
MedMira Inc. is a biotechnology company. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. It offers rapid tests for testing serum, plasma or whole blood specimens. The Company's tests are sold under brands, including Reveal, Multiplo and Miriad. The Company offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Gold Health Manufacturing Healthcare Flow Biotechnology Hiv Plasma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.135 |
| 52 Week Low | 0.07 |
| Average Volume | 59,230 |
| 200-Day Moving Average | 0.091 |
| 50-Day Moving Average | 0.084 |
| 20-Day Moving Average | 0.081 |
| 10-Day Moving Average | 0.082 |
| Average True Range | 0.005 |
| RSI (14) | 61.54 |
| ADX | 14.55 |
| +DI | 38.688 |
| -DI | 25.301 |
| Chandelier Exit (Long, 3 ATRs) | 0.079 |
| Chandelier Exit (Short, 3 ATRs) | 0.086 |
| Upper Bollinger Bands | 0.089 |
| Lower Bollinger Band | 0.072 |
| Percent B (%b) | 1.34 |
| BandWidth | 21.040 |
| MACD Line | 0.000 |
| MACD Signal Line | -0.001 |
| MACD Histogram | 0.001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.118 | ||||
| Resistance 3 (R3) | 0.115 | 0.105 | 0.114 | ||
| Resistance 2 (R2) | 0.105 | 0.099 | 0.106 | 0.112 | |
| Resistance 1 (R1) | 0.100 | 0.096 | 0.103 | 0.103 | 0.111 |
| Pivot Point | 0.090 | 0.090 | 0.091 | 0.091 | 0.090 |
| Support 1 (S1) | 0.085 | 0.084 | 0.088 | 0.088 | 0.079 |
| Support 2 (S2) | 0.075 | 0.081 | 0.076 | 0.078 | |
| Support 3 (S3) | 0.070 | 0.075 | 0.076 | ||
| Support 4 (S4) | 0.073 |
